Set Your Sights On Cymabay Therapeutics Inc (NASDAQ: CBAY)’S Upside Potential
Cymabay Therapeutics Inc (CBAY) concluded trading on Thursday at a closing price of $32.48, with 8.36 million shares of worth about $271.41 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 121.86% during that period and on March 21, 2024 the price saw a […]
Investors Should Take Note Of Cymabay Therapeutics Inc (CBAY)
Cymabay Therapeutics Inc (CBAY) concluded trading on Wednesday at a closing price of $32.44, with 4.14 million shares of worth about $134.44 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 84.11% during that period and on March 13, 2024 the price remained unchanged. […]
Following The Money: Institution’s Growing Stake In Cymabay Therapeutics Inc (NASDAQ: CBAY)
Cymabay Therapeutics Inc (CBAY) concluded trading on Thursday at a closing price of $32.19, with 7.89 million shares of worth about $254.09 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 129.76% during that period and on Thursday the price saw a loss of […]
Cymabay Therapeutics Inc (NASDAQ: CBAY) Has Another Chance To Impress You
Currently, there are 113.40M common shares owned by the public and among those 107.98M shares have been available to trade. Insiders at the company have transacted a total of 62 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 31 of these insider trades were purchases, […]
Is There More Upside Ahead For Cymabay Therapeutics Inc (NASDAQ: CBAY)
BlackRock Fund Advisors has recently announced that it has increased stake in Cymabay Therapeutics Inc (NASDAQ:CBAY) by 5.53%. After grabbing 7.0 million shares, the institutional investor is now in possession of 0.37 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.17% having worth around $133.88 million. Moreover, […]
Cymabay Therapeutics Inc (NASDAQ: CBAY): Do Not Miss The Gain Train
BlackRock Fund Advisors has recently announced that it has increased stake in Cymabay Therapeutics Inc (NASDAQ:CBAY) by 5.53%. After grabbing 7.0 million shares, the institutional investor is now in possession of 0.37 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.21% having worth around $114.63 million. Moreover, […]
